Literature DB >> 31784368

Preventing drug-resistant tuberculosis transmission.

Anastasia Koch1, Helen Cox2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31784368     DOI: 10.1016/S1473-3099(19)30613-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  23 in total

1.  Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection.

Authors:  Jincun Zhao; Ranawaka A P M Perera; Ghazi Kayali; David Meyerholz; Stanley Perlman; Malik Peiris
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.

Authors:  Lingshu Wang; Wei Shi; James D Chappell; M Gordon Joyce; Yi Zhang; Masaru Kanekiyo; Michelle M Becker; Neeltje van Doremalen; Robert Fischer; Nianshuang Wang; Kizzmekia S Corbett; Misook Choe; Rosemarie D Mason; Joseph G Van Galen; Tongqing Zhou; Kevin O Saunders; Kathleen M Tatti; Lia M Haynes; Peter D Kwong; Kayvon Modjarrad; Wing-Pui Kong; Jason S McLellan; Mark R Denison; Vincent J Munster; John R Mascola; Barney S Graham
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

3.  MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

Authors:  Corinna La Rosa; Jeff Longmate; Joy Martinez; Qiao Zhou; Teodora I Kaltcheva; Weimin Tsai; Jennifer Drake; Mary Carroll; Felix Wussow; Flavia Chiuppesi; Nicola Hardwick; Sanjeet Dadwal; Ibrahim Aldoss; Ryotaro Nakamura; John A Zaia; Don J Diamond
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

4.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

5.  Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.

Authors:  Fei Song; Robert Fux; Lisette B Provacia; Asisa Volz; Markus Eickmann; Stephan Becker; Albert D M E Osterhaus; Bart L Haagmans; Gerd Sutter
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

6.  Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.

Authors:  John H Beigel; Jocelyn Voell; Parag Kumar; Kanakatte Raviprakash; Hua Wu; Jin-An Jiao; Eddie Sullivan; Thomas Luke; Richard T Davey
Journal:  Lancet Infect Dis       Date:  2018-01-09       Impact factor: 25.071

7.  Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.

Authors:  Ivy Widjaja; Chunyan Wang; Rien van Haperen; Javier Gutiérrez-Álvarez; Brenda van Dieren; Nisreen M A Okba; V Stalin Raj; Wentao Li; Raul Fernandez-Delgado; Frank Grosveld; Frank J M van Kuppeveld; Bart L Haagmans; Luis Enjuanes; Dubravka Drabek; Berend-Jan Bosch
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

8.  Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.

Authors:  Nisreen M A Okba; V Stalin Raj; Ivy Widjaja; Corine H GeurtsvanKessel; Erwin de Bruin; Felicity D Chandler; Wan Beom Park; Nam-Joong Kim; Elmoubasher A B A Farag; Mohammed Al-Hajri; Berend-Jan Bosch; Myoung-Don Oh; Marion P G Koopmans; Chantal B E M Reusken; Bart L Haagmans
Journal:  Emerg Infect Dis       Date:  2019-10-17       Impact factor: 6.883

9.  Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.

Authors:  Kayvon Modjarrad; Christine C Roberts; Kristin T Mills; Amy R Castellano; Kristopher Paolino; Kar Muthumani; Emma L Reuschel; Merlin L Robb; Trina Racine; Myoung-Don Oh; Claude Lamarre; Faraz I Zaidi; Jean Boyer; Sagar B Kudchodkar; Moonsup Jeong; Janice M Darden; Young K Park; Paul T Scott; Celine Remigio; Ajay P Parikh; Megan C Wise; Ami Patel; Elizabeth K Duperret; Kevin Y Kim; Hyeree Choi; Scott White; Mark Bagarazzi; Jeanine M May; Deborah Kane; Hyojin Lee; Gary Kobinger; Nelson L Michael; David B Weiner; Stephen J Thomas; Joel N Maslow
Journal:  Lancet Infect Dis       Date:  2019-07-24       Impact factor: 25.071

10.  Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection.

Authors:  Hyoung-Shik Shin; Yeonjae Kim; Gayeon Kim; Ji Yeon Lee; Ina Jeong; Joon-Sung Joh; Hana Kim; Eunjin Chang; Soo Yeon Sim; Jun-Sun Park; Dong-Gyun Lim
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

View more
  2 in total

1.  Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols.

Authors:  Ryan Dinkele; Sophia Gessner; Andrea McKerry; Bryan Leonard; Ronnett Seldon; Anastasia S Koch; Carl Morrow; Melitta Gqada; Mireille Kamariza; Carolyn R Bertozzi; Brian Smith; Courtney McLoud; Andrew Kamholz; Wayne Bryden; Charles Call; Gilla Kaplan; Valerie Mizrahi; Robin Wood; Digby F Warner
Journal:  PLoS Pathog       Date:  2021-02-01       Impact factor: 6.823

2.  Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity.

Authors:  Sara Al Mahrouqi; Amal Gadalla; Saleh Al Azri; Salama Al-Hamidhi; Amina Al-Jardani; Abdullah Balkhair; Amira Al-Fahdi; Laila Al Balushi; Samiya Al Zadjali; Asmahan Mohammed Nasser Al Marhoubi; Hamza A Babiker
Journal:  PeerJ       Date:  2022-07-28       Impact factor: 3.061

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.